Your Article Summary
See Latest ArticlesCardioprotective growth factors
Cardiovascular Research, 06/30/09
Hausenloy DJ et al. - This article will review several of these cardioprotective growth factors with respect to their ability to confer direct myocardial protection, focusing on the underlying signalling pathways involved and their potential for clinical application.
Today in Myocardium/Pericardium...keeping you current
Receive free subspecialty "5-minute updates" via email
A Randomized, Double-Blind, Placebo-Controlled, Dose-Escalation Study of Intravenous Adult Human Mesenchymal Stem Cells (Prochymal) After Acute Myocardial Infarction
JACC - Journal of the American College of Cardiology, 12/08/09
Anti-perforin neutralizing antibody reduces myocardial injury in viral myocarditis
Cardiology in the Young, 12/08/09
Acute Myocardial Infarction and Coronary Artery Bypass Grafting Outcomes in Specialty and General Hospitals: Analysis of State Inpatient Data
Health Services Research, 12/08/09
Today in Prevention...keeping you current
Receive free subspecialty "5-minute updates" via email
Rosiglitazone was non-inferior to metformin plus sulphonylurea for CV events but increased risk of HF and fractures in type 2 diabetes
Evidence-Based Medicine, 12/08/09
Review: aspirin reduces vascular events but increases bleeding in primary and secondary prevention
Evidence-Based Medicine, 12/08/09
Review: aspirin does not reduce CV events but may reduce non-fatal stroke in peripheral artery disease
Evidence-Based Medicine, 12/08/09